Clinical trial
Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally…
NCT00238199 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00238199 |
|---|---|
| Title | Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer |
| Official title | Phase II Study of Calcitriol-Enhanced Docetaxel in Patients With Previously Untreated Metastatic or Locally Advanced Pancreatic Cancer |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, docetaxel |
| Enrollment | 25 |
| Start date | Jun 1, 2002 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Oct 13, 2005 |
| Last update posted | Apr 24, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: